Cns Pharmaceuticals Inc (CNSP)

07:20 AM

CNS Pharmaceuticals shares dip after CEO departure announcement - MSN

07:20 AM

Jan 27, 2026

CNS Pharmaceuticals says priority ‘is to transform’ how company operates - TipRanks

Jan 27, 2026

Jan 27, 2026

CNS Pharmaceuticals’ new CEO outlines strategic overhaul By Investing.com - Investing.com Canada

Jan 27, 2026

Jan 27, 2026

CNS Pharmaceuticals (NASDAQ: CNSP) Issues Shareholder Letter Outlining Strategic Review and Focus on TPI 287 - Digital Journal

Jan 27, 2026

Jan 27, 2026

CNS Pharmaceuticals Announces Strategic Review Focused on Lead Drug Candidate TPI 287 - citybuzz -

Jan 27, 2026

Jan 27, 2026

CNS Pharmaceuticals (CNSP) CEO Outlines Strategic Vision for Fut - GuruFocus

Jan 27, 2026

Jan 27, 2026

CNS Pharmaceuticals’ new CEO outlines strategic overhaul - Investing.com

Jan 27, 2026

Jan 27, 2026

CNS Pharmaceuticals Issues Letter to Shareholders - ACCESS Newswire

Jan 27, 2026

Jan 27, 2026

New CNS Pharmaceuticals CEO launches broad review built around lead cancer drug - Stock Titan

Jan 27, 2026

Jan 23, 2026

Breakout Move: Is CNS Pharmaceuticals Inc stock good for income investorsMarket Volume Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn

Jan 23, 2026

Jan 21, 2026

CNS Pharmaceuticals (NASDAQ:CNSP) Stock Price Up 3.3% – What’s Next? - Defense World

Jan 21, 2026

Jan 19, 2026

Is CNS Pharmaceuticals Inc. being accumulated by smart money2025 Major Catalysts & Precise Buy Zone Identification - bollywoodhelpline.com

Jan 19, 2026

Jan 15, 2026

CNS Pharma Stock Up Over 30% - Nasdaq

Jan 15, 2026

Jan 12, 2026

Weekly Trades: Is CNS Pharmaceuticals Inc in a long term uptrendJuly 2025 Fed Impact & Verified Short-Term Plans - baoquankhu1.vn

Jan 12, 2026

Jan 09, 2026

How CNS Pharmaceuticals Inc. stock compares to market leadersForecast Cut & AI Optimized Trading Strategy Guides - ulpravda.ru

Jan 09, 2026

Jan 08, 2026

How CNS Pharmaceuticals Inc. stock reacts to global recession fears2025 Price Targets & Growth Focused Investment Plans - Улправда

Jan 08, 2026

Jan 08, 2026

How CNS Pharmaceuticals Inc. stock performs after earningsJuly 2025 Summary & Detailed Earnings Play Alerts - Улправда

Jan 08, 2026

Jan 08, 2026

Should I hold or sell CNS Pharmaceuticals Inc. stock in 2025Earnings Risk Summary & Reliable Volume Spike Alerts - Улправда

Jan 08, 2026

Jan 08, 2026

Dividend Watch: How CNS Pharmaceuticals Inc. stock performs in rate cut cycles2025 Investor Takeaways & Accurate Trade Setup Notifications - Улправда

Jan 08, 2026

Jan 02, 2026

CNS Pharmaceuticals Inc. (CNSP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jan 02, 2026

Dec 28, 2025

CNS Pharmaceuticals (NASDAQ:CNSP) Stock Price Down 0.5% – Here’s Why - Defense World

Dec 28, 2025

Dec 27, 2025

Aug Reactions: How CNS Pharmaceuticals Inc stock performs in rate cut cycles2025 Top Gainers & Capital Efficient Trading Techniques - moha.gov.vn

Dec 27, 2025

Dec 23, 2025

CNS Pharmaceuticals names Rami Levin as new CEO following John Climaco’s departure - MSN

Dec 23, 2025

Dec 22, 2025

Whats Driving Tourism Finance Corporation of India Limited Stocks Recent Momentum Key TrendsCandlestick Trading Patterns & High Return Capital Strategies - earlytimes.in

Dec 22, 2025

Dec 20, 2025

Why CNS Pharmaceuticals Inc. stock is popular among millennialsJuly 2025 Update & Free Risk Controlled Daily Trade Plans - Улправда

Dec 20, 2025

Dec 20, 2025

Will CNS Pharmaceuticals Inc. stock remain a Wall Street favorite2025 Growth vs Value & Safe Entry Trade Signal Reports - Улправда

Dec 20, 2025

Dec 19, 2025

Is CNS Pharmaceuticals Inc. stock positioned well for digital economyQuarterly Earnings Report & High Conviction Buy Zone Picks - Улправда

Dec 19, 2025

Dec 19, 2025

CNSP (CNS Pharmaceuticals) EV-to-OCF : 0.34 (As of Dec. 19, 2025) - GuruFocus

Dec 19, 2025

Dec 18, 2025

CNSP (CNS Pharmaceuticals) EV-to-OCF : 0.34 (As of Dec. 18, 2025) - GuruFocus

Dec 18, 2025

Dec 18, 2025

CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco By Investing.com - Investing.com South Africa

Dec 18, 2025

Dec 18, 2025

CNS Pharmaceuticals Announces New CEO Appointment - The Globe and Mail

Dec 18, 2025

Dec 17, 2025

CNS Pharmaceuticals (NASDAQ: CNSP) Appoints Rami Levin as President and CEO - Digital Journal

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals Appoints Rami Levin as CEO to Advance Brain Cancer Pipeline - citybuzz -

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals appoints Rami Levin as CEO, John Climaco resigns By Investing.com - Investing.com Australia

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals appoints Rami Levin as CEO effective Jan 1, 2026 - marketscreener.com

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals stock falls after CEO steps down - Investing.com India

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals stock falls after CEO steps down By Investing.com - Investing.com Nigeria

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals appoints Rami Levin as CEO, John Climaco resigns - Investing.com

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals Announces CEO Transition - TradingView — Track All Markets

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals (CNSP) appoints new CEO Rami Levin and outlines Climaco severance - Stock Titan

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals (CNSP) Appoints New CEO - GuruFocus

Dec 17, 2025

Dec 17, 2025

CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco - Investing.com India

Dec 17, 2025

Dec 17, 2025

Brain cancer drug developer taps new CEO with global track record - Stock Titan

Dec 17, 2025

Dec 15, 2025

CNS Pharmaceuticals Earnings Notes - Trefis

Dec 15, 2025

Dec 12, 2025

Cycle buying Applied Therapeutics to develop CNS drugs - BioWorld MedTech

Dec 12, 2025

Dec 11, 2025

Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at 7th Annual CNS Delivery SummitSlideshow - Seeking Alpha

Dec 11, 2025